AR036793A1 - Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante - Google Patents
Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvanteInfo
- Publication number
- AR036793A1 AR036793A1 ARP020103816A ARP020103816A AR036793A1 AR 036793 A1 AR036793 A1 AR 036793A1 AR P020103816 A ARP020103816 A AR P020103816A AR P020103816 A ARP020103816 A AR P020103816A AR 036793 A1 AR036793 A1 AR 036793A1
- Authority
- AR
- Argentina
- Prior art keywords
- nucleic acid
- tumor antigen
- vaccines
- adjutive
- cytokin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/00117—Mucins, e.g. MUC-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
- A61K39/001194—Prostate specific antigen [PSA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se presentan vacunas de ácido nucleico que comprenden por lo menos un ácido nucleico que codifica un antígeno tumoral y por lo menos un ácido nucleico que codifica citoquina adyuvante para la profilaxis o tratamiento de tumores. Las vacunas virales se combinan optativamente o se administran además con un refuerzo de vacuna de virus recombinante o ADN. Reivindicación 1: Una vacuna de ácido nucleico que comprende (a) por lo menos un polinucleótido que codifica por lo menos una porción antigénica de por lo menos una secuencia de aminoácidos que comprende o es codificada por al menos una de las SEC.ID.NOS: 1-47 o variantes de las mismas, o una secuencia de ácido nucleico complementaria de las mismas y (b) por lo menos un polinucleótido que codifica por lo menos una porción codificadora adyuvante de por lo menos una secuencia de aminoácidos que comprende o es codificada por al menos una de las SEC.ID.NOS: 60-77 o variantes de las mismas, o una secuencia complementaria de las mismas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32837101P | 2001-10-10 | 2001-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036793A1 true AR036793A1 (es) | 2004-10-06 |
Family
ID=23280723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103816A AR036793A1 (es) | 2001-10-10 | 2002-10-10 | Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050261213A1 (es) |
| EP (1) | EP1507540A4 (es) |
| AR (1) | AR036793A1 (es) |
| AU (1) | AU2002326961A1 (es) |
| BR (1) | BR0206112A (es) |
| NO (1) | NO20032586L (es) |
| WO (1) | WO2003031569A2 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012141B2 (en) * | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| ATE466085T1 (de) * | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
| MXPA05010255A (es) * | 2003-03-24 | 2005-12-14 | Scripps Research Inst | Vacunas de adn contra crecimiento tumoral y metodos de uso de las mismas. |
| ES2623812T3 (es) | 2003-11-12 | 2017-07-12 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Vectores a medida para tratar y prevenir cáncer pancreático |
| EP1694364B1 (en) | 2003-11-12 | 2014-04-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | System for treating and preventing breast cancer |
| DK1839120T3 (da) * | 2004-12-21 | 2013-11-11 | Janssen Biotech Inc | Vektorer baseret på Anti-IL-12-antistoffer, værtsceller og fremgangsmåder til fremstilling og anvendelser |
| AU2006209246A1 (en) * | 2005-01-28 | 2006-08-03 | Biomodifying Llc | Anti-MUC1 alpha/beta antibodies |
| MY196581A (en) * | 2013-11-01 | 2023-04-19 | Pfizer | Vectors for Expression of Prostate-Associated Antigens |
| US20190125852A1 (en) * | 2016-06-03 | 2019-05-02 | Etubics Corporation | Compositions and methods for tumor vaccination using prostate cancer-associated antigens |
| MX2020002542A (es) | 2017-09-06 | 2020-07-20 | Univ Yale | Variantes de interleucina-18 y metodos de uso. |
| US11845952B2 (en) * | 2018-02-07 | 2023-12-19 | Nippon Medical School Foundation | Adeno-associated virus vector |
| CN108624691A (zh) * | 2018-06-22 | 2018-10-09 | 杭州西合精准医疗科技有限公司 | 一种用于判断前列腺疾病的标志物及其应用 |
| US12029778B2 (en) | 2019-05-13 | 2024-07-09 | Yale University | Interleukin-18 mimics and methods of use |
| BR112023003834A2 (pt) * | 2020-09-02 | 2023-03-28 | 4D Molecular Therapeutics Inc | Genes rpgrorf15 otimizados por códon e usos dos mesmos |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013268A (en) * | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
| DE19648625A1 (de) * | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| WO1999061068A1 (en) * | 1998-05-29 | 1999-12-02 | The Trustees Of The University Of Pennsylvania | Anti-prostate cancer vaccines, and methods of making, using and evaluating the same |
| US6387888B1 (en) * | 1998-09-30 | 2002-05-14 | American Foundation For Biological Research, Inc. | Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
| US6495130B1 (en) * | 1998-12-30 | 2002-12-17 | Calydon, Inc. | Target cell-specific adenoviral vectors containing E3 and methods of use thereof |
| AU2002239441A1 (en) * | 2000-11-01 | 2002-05-27 | American Foundation For Biological Research, Inc. | Methods and compositions for inducing cell-mediated immune responses |
-
2002
- 2002-09-18 WO PCT/US2002/029640 patent/WO2003031569A2/en not_active Ceased
- 2002-09-18 EP EP02761720A patent/EP1507540A4/en not_active Withdrawn
- 2002-09-18 AU AU2002326961A patent/AU2002326961A1/en not_active Abandoned
- 2002-09-18 BR BR0206112-0A patent/BR0206112A/pt not_active Application Discontinuation
- 2002-10-10 AR ARP020103816A patent/AR036793A1/es unknown
-
2003
- 2003-03-28 US US10/401,386 patent/US20050261213A1/en not_active Abandoned
- 2003-06-06 NO NO20032586A patent/NO20032586L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20050261213A1 (en) | 2005-11-24 |
| WO2003031569A2 (en) | 2003-04-17 |
| BR0206112A (pt) | 2005-05-10 |
| WO2003031569A3 (en) | 2004-12-29 |
| NO20032586L (no) | 2003-08-04 |
| AU2002326961A1 (en) | 2003-04-22 |
| EP1507540A2 (en) | 2005-02-23 |
| EP1507540A4 (en) | 2006-12-06 |
| NO20032586D0 (no) | 2003-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR036793A1 (es) | Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante | |
| ATE292685T1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| CA2408328A1 (en) | Immunogenic polypeptides encoded by mage minigenes and uses thereof | |
| RU2009123028A (ru) | F-белок респираторно-синцитиального вируса (rsv) и его применение | |
| DK217288D0 (da) | Dna, der indkoder t-celleoverfladeproteinet t4, og anvendelse af t4-fragmenter ved behandling af aids | |
| AR003425A1 (es) | Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv) | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| MXPA02006888A (es) | Flavivirus recombinantes y metodos para utilizar los mismos. | |
| JP2002542827A5 (es) | ||
| JP2003500040A5 (es) | ||
| WO2002022686A3 (en) | Defensin-antigen fusion proteins | |
| NO944245L (no) | Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner | |
| CA2617341A1 (en) | Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus | |
| CO5580165A1 (es) | Vacunas de rotavirus modificado | |
| RU2008102654A (ru) | Инактивированные химерные вакцины и связанные с ними способы применения | |
| JP2003530088A5 (es) | ||
| NZ237532A (en) | Gp75, nucleic acid encoding it, fragments and vaccines | |
| ES2039239T3 (es) | Vacuna contra el virus varicela-zoster. | |
| DE60228136D1 (de) | Cytokin-proteinfamilie | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| AU6683400A (en) | Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat | |
| PH12022550063A1 (en) | Vaccine | |
| PE20001287A1 (es) | Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral | |
| RU2007106900A (ru) | Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях | |
| EP1090995A3 (en) | Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |